Divestment for Artery-involved Pancreatic Cancer

Clinical trial NCT03443921 · UNKNOWN

Trial details

NCT number: NCT03443921
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Pancreatic Cancer Locally Advanced Pancreatic Cancer Neoadjuvant Therapy Borderline Resectable Pancreatic Cancer

Start date: 2018-03-01
Primary completion: 2019-03-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.